// App-Quantinova.ai

e14518 : Targeting OX40 by monoclonal antibody PF-04518600 to enhance T cell functions and inhibit tumor growth.

Researchers

Presenter

  • Hua Long

Principal Investigators

  • Ann L White

  • Brittany B Jiang

  • Reid Feldman

  • Danielle C Pappas

  • Aymen Al-Shamkhani

  • Changyu Wang

  • John Lin

Medical Centers

  • Rinat-Pfizer, South San Francisco, CA

  • University of Southampton, Southampten, United Kingdom

  • Rinat-Pfizer, South San Francisco, CA

  • Amgen Inc, South San Francisco, CA

Locations

  • United States

  • United Kingdom

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved